Analysis
Thatch raised a $108 million Series C at a $1 billion valuation, TechCrunch reported, with the round led by The General Partnership, Index Ventures, General Catalyst and Andreessen Horowitz. Strategic investors ADP Ventures, Paychex, Eli Lilly and Company, Scale Venture Partners, QuantumLight, SemperVirens, Quiet Capital and Avid Ventures also participated -- a mix of payroll incumbents and a major pharmaceutical company alongside the traditional venture backers.
Founded in San Francisco in October 2021 by chief executive Chris Ellis and president Adam Stevenson, Thatch sells an ICHRA marketplace -- Individual Coverage Health Reimbursement Arrangement, a mechanism created by federal regulation in 2020 that lets a company set a fixed pre-tax health budget per employee instead of enrolling everyone in a single group plan. Workers then use those funds to choose among dozens of health, dental and vision plans on Thatch's marketplace, with the company using AI to recommend a plan suited to each employee's needs. Both founders have said they were drawn to the problem after each lost a parent to cancer and experienced firsthand how confusing and rigid group health coverage can be during a health crisis.
Growth On Top Of A Regulatory Carve-Out
The company says revenue has grown nearly sevenfold over the past twelve months and that more than 5,000 employers now use the platform to move away from traditional group health plans. That growth rate follows a $40 million Series B the company raised in April 2025, meaning Thatch has now raised three rounds inside roughly eighteen months as employer interest in ICHRA has accelerated alongside rising healthcare costs. The closest adjacent player in individual-plan enrollment is HealthSherpa, though Thatch's pitch is aimed specifically at the employer-benefits administration layer rather than direct-to-consumer plan shopping.
The regulatory dependency is the detail worth sitting with. ICHRA exists because of a 2020 rule change under the first Trump administration, and its adoption has been gradual rather than universal -- most employers still default to traditional group plans, and Thatch's total addressable market is a function of how many companies actually switch models rather than how good Thatch's software is. That is a real tailwind today: employer group-plan premiums have climbed steadily for years, and ICHRA's individual-market flexibility becomes more attractive to a cost-conscious CFO with every renewal cycle that brings a double-digit premium increase. It is also a risk, because the same regulatory mechanism that created Thatch's market could in principle be narrowed by a future rule change, and demand tied this directly to a specific cost trend can soften if that trend moderates.
For a company now valued at $1 billion on $108 million raised in its Series C alone, the number that will matter most at the next round is retention through a full renewal cycle -- whether the 5,000 employers who adopted ICHRA through Thatch during a period of rising costs stay on the platform if premium growth ever slows, or whether some fraction reverts to the administrative simplicity of a single group plan once the cost pressure that drove them to switch eases.